Hepatitis C Virus RNA Viremia in Central Africa
To the Editor: Epidemiologic serosurveys have demonstrated high prevalence (6%-15%) of hepatitis C virus (HCV) infection in adults in sub-Saharan Africa (1) (2) (3) (4) . Although possible false-positive HCV serologic test results have been reported in Africa, HCV prevalence rates suggest a high rate of chronic infection among persons with anti-HCV antibodies (5, 6) . We have focused on HCV RNA infectivity of blood from donors attending the National Blood Center in Bangui, Central African Republic.
We prospectively tested all blood donors between February and April 1998 for serum anti-HCV antibodies by both an HCV thirdgeneration enzyme-linked immunosorbent assay (ELISA) (Abbott HCV EIA 3.0 test, Abbott, Chicago, IL, USA), which was chosen as a reference test for immunoglobulin (Ig) G antibodies to HCV, and by a simple membrane immunoassay system (Ortho HCV Ab Quik Pack, Ortho Diagnostic Systems Inc., Tokyo, Japan) (7). Anti-HCV-positive serum samples were further subjected to qualitative detection of HCV RNA by reverse transcription-polymerase chain reaction (AMPLICOR-HCV, Roche Diagnostic Systems, Inc., Branchburg, NJ, USA) (8) . Of 163 serum samples (mean age ± standard deviation, 30±8 years), 155 were from male blood donors, 83 (51%) from first-time donors, and 125 (77%) from donors in the recipients family. Fifteen (9.2%; 95% confidence interval [CI] 5%-15%) samples contained IgG to HCV by ELISA. Of the ELISApositive samples, 14 were positive by the Quik Pack assay (sensitivity, 93.0%); of the 148 remaining ELISA-negative samples, 147 were negative by the Quik Pack assay (specificity, 99.3%). The agreement between the results of the two methods was 98.7%. Of the 163 samples, 10 (6.1%; CI 95%: 3%-11%) were positive for HCV antibodies (by ELISA and rapid test) and for HCV RNA.
We confirmed a high prevalence of HCVseropositivity among blood donors in Bangui and the subsequent high rate of HCV RNA viremic blood donations. To offset the major risk for transfusion-acquired HCV in Central Africa we recommend screening donated blood for anti-HCV. When laboratory facilities to perform ELISA are not available, the Quik Pack system, Data on the incidence of vaccine-preventable diseases within a military population that had similar duties in the same location are rarely available. When data from the respective region are not available, disease incidence or prevalence in the host country may be substituted. These data, however, may be misleading since the military often does not have the same lifestyle as the native population. Plague, for instance, had an incidence rate of 8 per 100,000 in Namibia, but not a single case was reported in the South African Armed Forces (unpub. SAMS report: Disease Profile of South West Africa, 1989). If epidemiologic documentation for a host country is not available, data from neighboring countries may be useful.
Travelers diarrhea is the most frequent health problem abroad (1, 2) . Although the diarrhea is self-limited and lasts an average of 1 day with appropriate treatment (4 days without), the unproductive time may be detrimental to a military mission. Oral vaccines against the three most frequent causes of travelers diarrhea (enterotoxigenic Escherichia coli, Campylobacter spp., and rotavirus [1, 2] ) are being developed; the latter will be available soon (3). Hepatitis A, most frequent among the vaccine-preventable diseases (4), is 10 to 100 times more frequent than typhoid fever (4, 5) . Hepatitis B occurs mainly in expatriates, but infections have also been observed in tourists who have had unprotected casual sex (6). The incidence rate of rabies is unknown, but animal bites that may result in rabies virus transmission and thus necessitate postexposure prophylaxis are frequent (7) . Only anecdotal cases of diphtheria, tetanus, and tuberculosis have been reported (8) . Poliomyelitis, yellow fever, Japanese encephalitis, and plague occur only in limited parts of the world (5) . The situation may rapidly change as
